Zhao, S., Tao, X., Lin, Z., Wang, B., Liu, D., Zhan, B., Liu, H., Zhang, T., Tang, J., Xue, J. (2026). Stereotactic body radiotherapy plus cadonilimab and lenvatinib as conversion therapy for potentially resectable hepatocellular carcinoma (UniRTX): A phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16278